The roles of angiotensin-converting enzyme 2 inhibitor, melatonin and its agonist on angiotensin II reactivity in intact and denuded rat aortic rings

References

• Abbasnezhad A, Niazmand S, Mahmoudabady M, et al. Nigella sativa improve redox homeostasis in heart and aorta of diabetic rat. CNF. 2016;12(1):35–41. doi:10.2174/1573401311666150804213742.
   Google Scholar
• Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev. 2013;93(1):137–188. doi:10.1152/physrev.00045.2011.
   PubMed Web of Science ®Google Scholar
• Fountain JH, Lappin SL. 2017. Physiology, renin angiotensin system.
   Google Scholar
• Kuriakose J, Montezano AC, Touyz RM. ACE2/ang-(1-7)/Mas1 axis and the vascular system: vasoprotection to COVID-19-associated vascular disease. Clin Sci (Lond). 2021;135(2):387–407. doi:10.1042/CS20200480.
   PubMed Web of Science ®Google Scholar
• Verano-Braga T, Martins ALV, Motta-Santos D, et al. ACE2 in the renin–angiotensin system. Clin Sci. 2020;134(23):3063–3078. doi:10.1042/CS20200478.
   Web of Science ®Google Scholar
• Bernstein KE, Ong FS, Blackwell W-LB, et al. A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme. Pharmacol Rev. 2013;65(1):1–46. doi:10.1124/pr.112.006809.
   PubMed Web of Science ®Google Scholar
• Speck D, Kleinau G, Szczepek M, et al. Angiotensin and endothelin receptor structures with implications for signaling regulation and pharmacological targeting. Front Endocrinol. 2022;13:880002. doi:10.3389/fendo.2022.880002.
   PubMed Web of Science ®Google Scholar
• Cecon E, Oishi A, Jockers R. Melatonin receptors: molecular pharmacology and signalling in the context of system bias. Br J Pharmacol. 2018;175(16):3263–3280. doi:10.1111/bph.13950.
   PubMed Web of Science ®Google Scholar
• Vargas RAV, Millán JMV, Bonilla EF. Renin–angiotensin system: basic and clinical aspects—a general perspective. Endocrinol Diabetes Nutr. 2022;69:52–62.
   PubMed Web of Science ®Google Scholar
• Ghesmati Z, Rashid M, Fayezi S, et al. An update on the secretory functions of brown, white, and beige adipose tissue: towards therapeutic applications. Rev Endocr Metab Disord. 2024;25(2):279–308.
   PubMed Web of Science ®Google Scholar
• Ciftciler R, Haznedaroglu IC. Pathobiological interactions of local bone marrow renin-angiotensin system and Central nervous system in systemic arterial hypertension. Front Endocrinol. 2020;11:544262.
   Web of Science ®Google Scholar
• Mohanta SK, Peng L, Li Y, et al. Neuroimmune cardiovascular interfaces control atherosclerosis. Nature. 2022;605(7908):152–159. doi:10.1038/s41586-022-04673-6.
   PubMed Web of Science ®Google Scholar
• Paulo M, Costa DE, Bonaventura D, et al. Nitric oxide donors as potential drugs for the treatment of vascular diseases due to endothelium dysfunction. Curr Pharm Des. 2020;26(30):3748–3759. doi:10.2174/1381612826666200519114442.
   PubMed Web of Science ®Google Scholar
• Barsha G, Mirabito Colafella KM, Walton SL, et al. In aged females, the enhanced pressor response to angiotensin II is attenuated by estrogen replacement via an angiotensin type 2 receptor-mediated mechanism. Hypertension. 2021;78(1):128–137. doi:10.1161/HYPERTENSIONAHA.121.17164.
   PubMed Web of Science ®Google Scholar
• Bian J, Lei J, Yin X, et al. Limited AT1 receptor internalization is a novel mechanism underlying sustained vasoconstriction induced by AT1 receptor autoantibody from preeclampsia. J Am Heart Assoc. 2019;8(6):e011179. doi:10.1161/JAHA.118.011179.
   PubMed Web of Science ®Google Scholar
• Smit-VAN Schalkwyk M. 2016. Rooibos and melatonin: putative modulation of nicotine-induced effects on vascular function. Stellenbosch: stellenbosch University.
   Google Scholar
• Dominguez‐rodriguez A, Abreu‐gonzalez P, Sanchez‐sanchez JJ, et al. Melatonin and circadian biology in human cardiovascular disease. J Pineal Res. 2010;49(1):14–22. doi:10.1111/j.1600-079X.2010.00773.x.
   PubMed Web of Science ®Google Scholar
• Candia AA, Arias PV, González-Candia C, et al. Melatonin treatment during chronic hypoxic gestation improves neonatal cerebrovascular function. Vascul Pharmacol. 2022;144:106971. doi:10.1016/j.vph.2022.106971.
   PubMed Web of Science ®Google Scholar
• Xu Z, Wu Y, Zhang Y, et al. Melatonin activates BKCa channels in cerebral artery myocytes via both direct and MT receptor/PKC-mediated pathway. Eur J Pharmacol. 2019;842:177–188. doi: 10.1016/j.ejphar.2018.10.032.
   PubMed Web of Science ®Google Scholar
• Simko F, Reiter RJ, Paulis L. Melatonin as a rational alternative in the conservative treatment of resistant hypertension. Hypertens Res. 2019;42(11):1828–1831. doi:10.1038/s41440-019-0318-3.
   PubMed Web of Science ®Google Scholar
• Stennett AK, Qiao X, Falone AE, et al. Increased vascular angiotensin type 2 receptor expression and NOS-mediated mechanisms of vascular relaxation in pregnant rats. Am J Physiol Heart Circ Physiol. 2009;296(3):H745–55. doi:10.1152/ajpheart.00861.2008.
   PubMed Web of Science ®Google Scholar
• Paulis L, Simko F. Blood pressure modulation and cardiovascular protection by melatonin: potential mechanisms behind. Physiol Res. 2007;56(6):671–684. doi:10.33549/physiolres.931236.
   PubMed Web of Science ®Google Scholar
• Baker J, Kimpinski K. Role of melatonin in blood pressure regulation: an adjunct anti‐hypertensive agent. Clin Exp Pharmacol Physiol. 2018;45(8):755–766. doi:10.1111/1440-1681.12942.
   PubMed Web of Science ®Google Scholar
• Zhao T, Zhang H, Jin C, et al. Melatonin mediates vasodilation through both direct and indirect activation of BKCa channels. J Mol Endocrinol. 2017;59(3):219–233. doi:10.1530/JME-17-0028.
   PubMed Web of Science ®Google Scholar
• Zarezadeh M, Barzegari M, Aghapour B, et al. Melatonin effectiveness in amelioration of oxidative stress and strengthening of antioxidant defense system: findings from a systematic review and dose-response meta-analysis of controlled clinical trials. Clin Nutr ESPEN. 2022;48:109–120. doi:10.1016/j.clnesp.2022.01.038.
   PubMed Web of Science ®Google Scholar
• Miyamoto M. Pharmacology of ramelteon, a selective MT1/MT2 receptor agonist: a novel therapeutic drug for sleep disorders. CNS Neurosci Ther. 2009;15(1):32–51. doi:10.1111/j.1755-5949.2008.00066.x.
   PubMed Web of Science ®Google Scholar
• Yalcin HC, Sukumaran V, Al-Ruweidi MKA, et al. Do changes in ace-2 expression affect sars-cov-2 virulence and related complications: a closer look into membrane-bound and soluble forms. Int J Mol Sci. 2021;22(13):6703. doi:10.3390/ijms22136703.
   PubMed Web of Science ®Google Scholar
• Kassiri Z, Zhong J, Guo D, et al. Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction. Circ Heart Fail. 2009;2(5):446–455. doi:10.1161/CIRCHEARTFAILURE.108.840124.
   PubMed Web of Science ®Google Scholar
• Maier C, Schadock I, Haber PK, et al. Prolylcarboxypeptidase deficiency is associated with increased blood pressure, glomerular lesions, and cardiac dysfunction independent of altered circulating and cardiac angiotensin II. J Mol Med (Berl). 2017;95(5):473–486. doi:10.1007/s00109-017-1513-9.
   PubMed Web of Science ®Google Scholar
• Serfozo P, Wysocki J, Gulua G, et al. Ang II (angiotensin II) conversion to angiotensin-(1-7) in the circulation is POP (prolyloligopeptidase)-dependent and ACE2 (angiotensin-converting enzyme 2)-independent. Hypertension. 2020;75(1):173–182. doi:10.1161/HYPERTENSIONAHA.119.14071.
   PubMed Web of Science ®Google Scholar